SCRI - Nashville — Nashville, Tennessee

SCRI - Nashville is a clinical research site located in Nashville, Tennessee, United States 37023.

Crixeo Health Trust Score: 58/100 (POOR). This profile has not yet been claimed by the site owner.

SCRI - Nashville has participated in 2 clinical trials with 2 currently active.

Therapeutic areas: Advanced Solid Malignancies, Solid Tumor.

Sponsors: Treadwell Therapeutics, Inc, Corbus Pharmaceuticals Inc..

Sponsor Feasibility Report

Trust Score: 58/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for SCRI - Nashville?

SCRI - Nashville has a Crixeo Trust Score of 58/100 (POOR). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has SCRI - Nashville conducted?

SCRI - Nashville has 2 clinical trials on record, with 2 currently active. Their work covers Advanced Solid Malignancies, Solid Tumor.

Is SCRI - Nashville accredited by Crixeo Health?

SCRI - Nashville has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about SCRI - Nashville?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.